Burroughs Wellcome: Following Glaxo's footsteps - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Burroughs Wellcome: Following Glaxo's footsteps

Jul 26, 2000

Burroughs Wellcome has followed Glaxo's footsteps in declaring impressive second quarter results. While turnover has increased 22.9%, the bottomline has jumped more than 35%.

(Rs m) 2QFY99 2QFY00 Change
Sales 489 601 22.9%
Other Income 43 40 -7.2%
Expenditure 398 479 20.3%
Operating Profit (EBDIT) 91 122 34.6%
Operating Profit Margin (%) 18.5% 20.3%  
Interest 7 4  
Depreciation 6 6 -11.3%
Profit before Tax 121 153 26.5%
Other Adjustments      
Tax 48 55  
Profit after Tax/(Loss) 72 98 35.3%
Net profit margin (%) 14.8% 16.3%  
No. of Shares (m) (eoy) 9.2 9.2  
Diluted no. of shares (m) 9.2 9.2  
Diluted Earnings per share* 31.5 42.6  
*(annualised)      

Though Burroughs Wellcome has an older portfolio of products as compared to Glaxo, the company has an advantage in that lesser number of its brands fall under the Drug Price Control Order. However, what products have led the company's topline growth will only be confirmed at the analysts meet tomorrow.

The company is not being amalgamated with Glaxo primarily due to the fact that payscales at Burroughs are higher than those at Glaxo. While the workers are unwilling to shift to lower payscales, the management is unwilling to increase the payscales overall, to prevalent levels in Burroughs.

The stock quotes at Rs 340 which implies an earning multiple of 8 times of calender year 2000 earnings.


Equitymaster requests your view! Post a comment on "Burroughs Wellcome: Following Glaxo's footsteps". Click here!

  

More Views on News

Sorry! There are no related views on news for this company/sector.

Most Popular

How the 8-Year Cycle Can Help Identify Multibaggers (Fast Profits Daily)

Sep 11, 2020

This is how you can apply the greed and fear cycle in the market to pick stocks.

I Recommended this Stock over Page Industries because it's Relevant to Doubling Your Income (Profit Hunter)

Sep 7, 2020

Things are not often what they seem in the market and how you can take advantage of this.

The NASDAQ Whale Could Harm Your Portfolio (Fast Profits Daily)

Sep 7, 2020

The discovery of Softbank pushing up prices on the NASDAQ will cause volatility in the market. Stay alert!

This Could Be the Best September for Auto Stocks (Profit Hunter)

Sep 11, 2020

Here's why I think this month could be a great for auto stocks.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

TRACK BURROUGH WEL

  • Track your investment in BURROUGH WEL with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MARKET STATS